Diseases, Conditions, Syndromes

Malaria vaccine 'first to meet WHO efficacy target'

A malaria vaccine candidate tested on children in West Africa has shown an efficacy of around 77 percent, say scientists, hailing it as a breakthrough in the fight against the disease.

Pediatrics

Novavax starts COVID-19 vaccine trials on children

US biotech firm Novavax said Monday it had started clinical trials of its proposed COVID-19 vaccine on children, in a program that will involve up to 3,000 adolescents aged 12-17.

Vaccination

EU regulator 'convinced' AstraZeneca benefit outweighs risk

The European Union's drug regulator insisted Tuesday that there is "no indication" the AstraZeneca vaccine causes blood clots as governments around the world faced the grimmest of dilemmas: push on with a vaccine known to ...

page 8 from 40